ILTS 2012 Report – Casting wide net for donated livers is worthwhile
by Thomas R. Collins – Pursuing liver grafts in an aggressive manner throughout the United States is much more costly than getting them from a local or regional… read more.
by Thomas R. Collins – Pursuing liver grafts in an aggressive manner throughout the United States is much more costly than getting them from a local or regional… read more.
by Thomas R. Collins – Doing a biopsy on a liver before the organ is procured for transplantation is helpful only when done for certain potential organ donors,
by Thomas R. Collins – With a scarcity of livers available for transplantation, there is a tremendous pressure on the medical community to make the best use of… read more.
by Thomas R. Collins – A living donor liver transplant can be a safe and effective first-line treatment for very young children with biliary atresia,
by Thomas R. Collins – Establishing and adhering to management goals for organ donors boosts the percentage of livers that are utilized,
Dr Irene Scalera, Fellow at the Liver Unit at Queen Elizabeth Hospital, Birmingham, describes the ever-changing donor landscape and attempts to improve liver donor shortage.
Findings from a newly published meta-analysis suggests that levels of non-high-density lipoprotein cholesterol (non-HDL-C) among statin users is associated with risk of developing a major cardiovascular event, such… read more.
Mood and anxiety disorders such as bipolar, panic disorder and major depressive disorder appear to be highly associated with non-medical prescription opioid use.
by Bruce Sylvester – Women with breast pain who undergo extra-routine mammograms, MRIs or ultrasounds as part of breast pain evaluation derive no diagnostic or therapeutic benefit, researchers… read more.
Paper presented on 5th June at ASCO – by Bruce Sylvester – The antidepressant duloxetine (Cymbalta ®), relieves neuropathic pain caused by chemotherapy in 59 percent of patients,… read more.
by Bruce Sylvester – Researchers from a Phase III study report no difference in rates of viral clearance between two anemia management strategies for patients with chronic hepatitis… read more.
by Bruce Sylvester – Researchers report that patients with genotype 2 or 3 hepatitis C virus (HCV) treated with investigative pegylated interferon lambda-1a (peg-IFN-lambda 1a, Bristol-Myers Squibb) in… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.